Objective: To compare the level of sedation, cardiorespiratory changes, and quality of recovery in cats receiving methadone plus either low dose tiletamine-zolazepam or acepromazine for premedication prior to general anaesthesia for neutering.
Study Design: Prospective, randomized, blinded clinical study.
Animals: Twenty cats 0.54 ± 0.12 years-old (mean ± SD), weighing 3.17 ± 0.65 kg (10 male and 10 female).
Methods: Cats were allocated randomly to receive intramuscularly either 0.03 mg kg(-1) acepromazine (ACE) or 3 mg kg(-1) tiletamine-zolazepam (TZ), both regimens combined with 0.2 mg kg(-1) methadone for premedication. Sedation was assessed 25 minutes after premedication using a visual analogue scale (VAS) and a simple descriptive scale (SDS). Anaesthesia was induced with alfaxalone and maintained with isoflurane. Physiological parameters were recorded at 1, 3 and 5 minutes post-endotracheal intubation. Recovery from cessation of isoflurane was timed and quality assessed using a SDS and a VAS. Data was analysed with Mann-Whitney U-test, students t-test, anova or ordinal logistic regression as relevant. Significance was taken as p < 0.05.
Results: Sedation was more pronounced in TZ than ACE as indicated by higher VAS (67 ± 21 versus 13 ± 5) and SDS scores [4 (1-4) versus 1 (0-1)]. Following sedation, Heart (HR) and respiratory (fR ) rates did not differ between groups. After anaesthetic induction, at times 1, 3 and 5 HR, systolic arterial pressure and end tidal carbon dioxide were significantly higher and fR was significantly lower in TZ than ACE. Recovery quality was similar between groups. In both groups, times to extubation, head lift and sternal recumbency were similar, but time (minutes) until standing was significantly longer in TZ (31 ± 16) than ACE (18 ± 11).
Conclusion And Clinical Relevance: Low dose tiletamine-zolazepam combined with methadone provided superior sedation to ACE. Recovery quality was similar, although time to standing was longer.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/vaa.12161 | DOI Listing |
Photochem Photobiol Sci
January 2025
Homi Bhabha National Institute, Training School Complex, Anushaktinagar, Mumbai, 400094, India.
The efficacy of photodynamic treatment (PDT) against deep-seated tumor is hindered by low penetration depth of light as well as hypoxic conditions which prevails in tumor. To overcome this limitation, Near-infrared (NIR) absorbing photosensitizers have been investigated actively. In the present study we evaluated the PDT efficacy of an NIR absorbing chlorophyll derivative 'Cycloimide Purpurin-18 (CIPp-18)' in Human Breast carcinoma (MCF-7) and cervical adenocarcinoma (Hela) cells under normoxic and hypoxic conditions.
View Article and Find Full Text PDFClin Rheumatol
January 2025
Department of Public Health, University of Murcia, Campus de Ciencias de la Salud, Murcia, 30120, Spain.
Introduction: Therapeutic drug monitoring (TDM) in inflammatory rheumatic diseases (RMDs) is gaining interest. However, there are unresolved questions about the best practices for implementing TDM effectively in clinical settings.
Objective: The primary objective of this study was to evaluate whether early TDM of adalimumab predicts drug survival at 52 weeks in patients with RMDs.
Tissue Eng Regen Med
January 2025
Department of Plastic Surgery, Hand Surgery-Burn Center, University Hospital RWTH Aachen, Pauwelsstraße 30, 52074, Aachen, Germany.
Background: Because of its biocompatibility and its soft and dynamic nature, the grafting of adipose tissue is regarded an ideal technique for soft-tissue repair. The adipose stem cells (ASCs) contribute significantly to the regenerative potential of adipose tissue, because they can differentiate into adipocytes and release growth factors for tissue repair and neovascularization to facilitate tissue survival. The present study tested the effect of administering a chronic low dose of ∆-tetrahydrocannabinol (THC) on these regenerative properties, in vitro and in vivo.
View Article and Find Full Text PDFVenetoclax plus azacitidine represents a key advance for older, unfit patients with acute myeloid leukemia (AML). The chemotherapy and venetoclax in elderly AML trial (CAVEAT) was first to combine venetoclax with intensive chemotherapy in newly diagnosed patients ≥65 years. In this final analysis, 85 patients (median age 71 years) were followed for a median of 41.
View Article and Find Full Text PDFInt J Cancer
January 2025
Jockey Club School of Public Health and Primary Care, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR.
Long-term use of low-dose aspirin has been demonstrated to reduce cancer risk, but the duration of necessary medication use remains uncertain. This study aimed to investigate the long-term chemoprotective effect of aspirin among the Chinese population. This population-based study included all aspirin users between 2000 and 2019.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!